141 related articles for article (PubMed ID: 301159)
21. Factor VIII procoagulant protein.
Zimmerman TS; Fulcher CA
Clin Haematol; 1985 Jun; 14(2):343-58. PubMed ID: 3930116
[No Abstract] [Full Text] [Related]
22. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
[TBL] [Abstract][Full Text] [Related]
23. [Determination of factor VIII antigen (VIIIR-Ag) by erythrocyte agglutination].
Coelho E
Rev Hosp Clin Fac Med Sao Paulo; 1987; 42(6):273-6. PubMed ID: 3138751
[No Abstract] [Full Text] [Related]
24. A 1973 look at hemophilia and von Willebrand's disease.
Ratnoff OD
Proc Inst Med Chic; 1973; 29(9):296-304. PubMed ID: 4581203
[No Abstract] [Full Text] [Related]
25. Response of patients with hemophilia A and von Willebrand disease to desmopressin (DDAVP).
Santiago-Borrero PJ; Casanova R
Bol Asoc Med P R; 1990 May; 82(5):207-10. PubMed ID: 2115785
[TBL] [Abstract][Full Text] [Related]
26. Molecular genetics of factor VIII and its disorders.
Bloom AL; Peake IR
Semin Hematol; 1977 Jul; 14(3):319-39. PubMed ID: 327558
[No Abstract] [Full Text] [Related]
27. [Inactive factor VIII in hemophilia A and Willebrand's disease].
Lechner K
Verh Dtsch Ges Inn Med; 1972; 78():710-3. PubMed ID: 4541862
[No Abstract] [Full Text] [Related]
28. [Normal and abnormal values of antihemophilic globulin (AHG): interpretation of the test results].
Matsuoka M; Toida K
Nihon Rinsho; 1969 Mar; ():Suppl:991-9. PubMed ID: 4948306
[No Abstract] [Full Text] [Related]
29. [Importance of the study of the binding of factor VIII to von Willebrand factor in hemophilia A].
Batlle J; Blanco-López MJ; Castiñeira MP; López-Fernández MF
Sangre (Barc); 1992 Jun; 37(3):211-24. PubMed ID: 1359656
[No Abstract] [Full Text] [Related]
30. Studies on the response of patients with classic hemophilia to transfusion with concentrates of antihemophilic factor. A difference in the half-life of antihemophilic factor as measured by procoagulant and immunologic techniques.
Bennett B; Ratnoff OD
J Clin Invest; 1972 Oct; 51(10):2593-6. PubMed ID: 4626847
[TBL] [Abstract][Full Text] [Related]
31. [Use of a basic study profile for diagnostic certainty in hemophilia A].
Ambriz-Fernández R; Avilés-Miranda A; Reyna-Fregoso MP; Ballesteros-Téllez L; Pizzuto-Chávez J
Gac Med Mex; 1983 Dec; 119(12):477-82. PubMed ID: 6421644
[No Abstract] [Full Text] [Related]
32. Influence of high molecular weight factor VIII on the measurement of low molecular weight factor VIII procoagulant in different assay systems.
Muntean W; Hathaway WE; Montgomery RR
Br J Haematol; 1982 Aug; 51(4):649-58. PubMed ID: 6809034
[No Abstract] [Full Text] [Related]
33. [Structure and function of clotting factor VIII: the results of fundamental research].
Beck EA; Furlan M
Ther Umsch; 1979 Apr; 36(4):294-300. PubMed ID: 377554
[No Abstract] [Full Text] [Related]
34. Low-molecular-weight factor VIII.
Bloom AL; Giddings JC; Peake IR
Lancet; 1973 May; 1(7810):1000. PubMed ID: 4121554
[No Abstract] [Full Text] [Related]
35. Immunologic heterogeneity of hemophilia.
Colman RW
N Engl J Med; 1973 Feb; 288(7):369-70. PubMed ID: 4539474
[No Abstract] [Full Text] [Related]
36. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
Orsini F; Rotschild C; Beurrier P; Faradji A; Goudemand J; Polack B
Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
[TBL] [Abstract][Full Text] [Related]
37. Endothelial cells and the biology of factor VIII.
Jaffe EA
N Engl J Med; 1977 Feb; 296(7):377-83. PubMed ID: 299915
[No Abstract] [Full Text] [Related]
38. Factor VIII/von Willebrand factor.
Zimmerman TS; Ruggeri ZM; Fulcher CA
Prog Hematol; 1983; 13():279-309. PubMed ID: 6422506
[No Abstract] [Full Text] [Related]
39. Immunologic studies of antihemophilic factor (AHF, factor VIII): cross-reacting material in a genetic variant of hemophilia A.
Hoyer LW; Breckenridge RT
Blood; 1968 Dec; 32(6):962-71. PubMed ID: 5303720
[No Abstract] [Full Text] [Related]
40. Immunologic studies in von Willebrand's disease. Evidence that the antihemophilic factor (AHF) produced after transfusions lacks an antigen associated with normal AHF and the inactive material produced by patients with classic hemophilia.
Bennett B; Ratnoff OD; Levin J
J Clin Invest; 1972 Oct; 51(10):2597-601. PubMed ID: 4115706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
